InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Jan-Fredrik Wilhelm Backman. Director active across 1 company, notably IRLAB Therapeutics AB (publ). In total, 2 filings have been published. History available since 17 July 2026. The latest transaction was disclosed on 17 July 2026 (Purchase). Regulator: FIN-FSA. All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations